EQRx to Participate at Upcoming Investor Conferences

Rhea-AI Summary

EQRx, a pharmaceutical company focused on delivering innovative medicines at lower prices, announced participation in two investor conferences in June 2022. The Jefferies Global Healthcare Conference will feature a fireside chat on June 9, 2022, at 11:30 a.m. PT, while the Goldman Sachs 43rd Annual Global Healthcare Conference will host a chat on June 14, 2022, at 4:00 p.m. PT. Live webcasts of these discussions will be accessible on EQRx's website. The company aims to revolutionize the pharmaceutical sector with cost-effective and efficient drug development.

CAMBRIDGE, Mass., May 31, 2022 (GLOBE NEWSWIRE) -- EQRx, Inc. (Nasdaq: EQRX), a new type of pharmaceutical company committed to developing and delivering innovative medicines to patients at radically lower prices, today announced that management will participate in the following investor conferences in June:

• Jefferies Global Healthcare Conference
  Fireside Chat: Thursday, June 9, 2022, 11:30 a.m. PT / 2:30 p.m. ET
  

• Goldman Sachs 43^rd Annual Global Healthcare Conference
  Fireside Chat: Tuesday, June 14, 2022, 4:00 p.m. PT / 7:00 p.m. ET
  

Live and archived webcasts of the fireside chats will be available by visiting the News & Events section of EQRx’s website, and selecting Events & Presentations, at investors.eqrx.com.

About EQRx
EQRx is a new type of pharmaceutical company committed to developing and delivering innovative medicines to patients at radically lower prices. Launched in January 2020, EQRx is purpose-built, at scale, with a growing catalog of medicines in development in high-cost drug categories and emerging partnerships with leading payers and providers. Leveraging cutting-edge science and technology and strategic partnerships with stakeholders from across the healthcare system, EQRx aims to provide innovative, patent-protected medicines more efficiently and cost-effectively than ever before. To learn more, visit www.eqrx.com and follow us on social media: Twitter: @EQRxInc, LinkedIn, Instagram: @eqrxinc.

EQRx™ and Remaking Medicine™ are trademarks of EQRx.

EQRx Contacts:

Media:
Dan Budwick
1AB
dan@1abmedia.com
  
Investors:
investors@eqrx.com

FAQ

What investor conferences is EQRx participating in June 2022?

EQRx is participating in the Jefferies Global Healthcare Conference on June 9, 2022, and the Goldman Sachs 43rd Annual Global Healthcare Conference on June 14, 2022.

When is the Jefferies Global Healthcare Conference for EQRx?

The Jefferies Global Healthcare Conference for EQRx is scheduled for June 9, 2022, at 11:30 a.m. PT.

What is the schedule for EQRx's Goldman Sachs conference?

EQRx's Goldman Sachs 43rd Annual Global Healthcare Conference will take place on June 14, 2022, at 4:00 p.m. PT.

How can I access EQRx's conference webcasts?

Live and archived webcasts of EQRx's conference chats will be available on their website in the News & Events section.

What is EQRx's mission in the pharmaceutical industry?

EQRx is committed to developing and delivering innovative medicines at radically lower prices, utilizing cutting-edge science and strategic partnerships.